The use of oxybutynin for treating axillary hyperhidrosis

Ann Vasc Surg. 2011 Nov;25(8):1057-62. doi: 10.1016/j.avsg.2011.06.007.

Abstract

Background: To evaluate the effectiveness and patient satisfaction with the use of oxybutynin for treating axillary hyperhidrosis in a large series of patients.

Methods: One hundred two patients with axillary hyperhidrosis were treated with oxybutynin. During the first week, patients received 2.5 mg of oxybutynin once a day in the evening. From the 8th to the 42nd day, they received 2.5 mg twice a day, and from the 43rd day to the end of the 12th week, they received 5 mg twice a day. All of the patients underwent two evaluations: before and after (12 weeks) the oxybutynin treatment, using a clinical questionnaire; and a clinical protocol for quality of life (QOL).

Results: More than 80% of the patients experienced an improvement in axillary hyperhidrosis; 36.3% of them presented a great improvement, and half of the patients showed improvements at all hyperhidrosis sites. Most of the patients showed improvements in the QOL (67.5%). The patients with very poor QOL before the treatment presented greater satisfaction levels after treatment. The side effects were minor, dry mouth being the most frequent (73.5%).

Conclusions: Oxybutynin is a good alternative to sympathectomy. It presents good results and improves QOL without the side effects of sympathectomy.

MeSH terms

  • Adolescent
  • Adult
  • Axilla
  • Brazil
  • Chi-Square Distribution
  • Drug Administration Schedule
  • Female
  • Humans
  • Hyperhidrosis / drug therapy*
  • Hyperhidrosis / physiopathology
  • Male
  • Mandelic Acids / administration & dosage*
  • Mandelic Acids / adverse effects
  • Middle Aged
  • Muscarinic Antagonists / administration & dosage*
  • Muscarinic Antagonists / adverse effects
  • Patient Satisfaction
  • Quality of Life
  • Surveys and Questionnaires
  • Sweating / drug effects*
  • Time Factors
  • Treatment Outcome
  • Young Adult

Substances

  • Mandelic Acids
  • Muscarinic Antagonists
  • oxybutynin